Corcept Therapeutics (CORT) shares outstanding

Shares outstanding · fiscal 2025
119.99M

Corcept Therapeutics (CORT) had 119.99M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is 5.7% higher than the 113.48M of fiscal 2024. Figures as of 18 Nov 2026, 11:52 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Shares outstanding, fiscal 2025
119.99M
Change on fiscal 2024
+5.7%
Growth, 5 years
−0.7% a year
Growth, 10 years
+1.2% a year
Highest on record
126.69Mfiscal 2018
Lowest on record
100.98Mfiscal 2014
Fiscal years on record
122014–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Corcept Therapeutics shares outstanding, in more detail

The market data feed counts 109.44M shares outstanding today.

Over the five fiscal years to 2025 the diluted share count shrank at a compound 0.7% a year; over ten years the rate was 1.2% a year. Across the 12 fiscal years on record (2014–2025), the highest was 126.69M in fiscal 2018 and the lowest 100.98M in fiscal 2014.

History · 12 fiscal years

Shares outstanding by fiscal year

Corcept Therapeutics shares outstanding, year by year

Corcept Therapeutics (CORT) shares outstanding by fiscal year
Fiscal yearShares outstandingChangeYear ended
2025119.99M 5.7% up
2024113.48M 1.6% up
2023111.74M 3.6% down
2022115.97M 7.9% down
2021125.96M 1.4% up
2020124.19M 1.3% up
2019122.57M 3.3% down
2018126.69M 1.7% up
2017124.52M 7.2% up
2016116.14M 8.7% up
2015106.88M 5.8% up
2014100.98M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed.

How to read it

A falling count means buybacks are giving each remaining share a larger slice of the company; a rising one means owners are being diluted.

Shares outstanding at health care companies of similar size

Shares outstanding of Corcept Therapeutics and comparable companies
CompanyShares outstandingFiscal year
Corcept Therapeutics CORT119.99M2025
Alkermes ALKS168.74M2025
PACS Group PACS156.70M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on CORT

Corcept Therapeutics, figure by figure

Corcept Therapeutics (CORT) overview: price, valuation and scorecardAll health care companies by market value

Corcept Therapeutics shares outstanding: questions and answers

How many shares does Corcept Therapeutics have?

Corcept Therapeutics (CORT) had 119.99M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is 5.7% higher than the 113.48M of fiscal 2024. The market data feed counts 109.44M shares outstanding today.

What is the growth rate of Corcept Therapeutics's diluted share count?

Over the five fiscal years to 2025 the diluted share count shrank at a compound 0.7% a year; over ten years the rate was 1.2% a year.

What are the highest and lowest diluted share count figures on record for Corcept Therapeutics?

Across the 12 fiscal years on record (2014–2025), the highest was 126.69M in fiscal 2018 and the lowest 100.98M in fiscal 2014.

How is Corcept Therapeutics's diluted share count calculated?

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed. For Corcept Therapeutics it is on record here for 12 fiscal years, 2014 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Corcept Therapeutics (CORT) shares outstanding”, data as of 18 November 2026. https://funkfolio.com/stock/CORT/shares-outstanding

Underlying data: the company's filings with the SEC and Yahoo Finance.